C4 Therapeutics to Participate in Upcoming September Investor Conferences
Provided By GlobeNewswire
Last update: Aug 29, 2024
WATERTOWN, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that C4T management will participate in fireside chats at two September investor conferences.
Read more at globenewswire.com
